Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02712983
Brief Title: Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection (iBEST-1)

First Submitted : February 5, 2016
First Submitted that Met QC Criteria : March 14, 2016
First Posted : March 18, 2016 (Estimate)

Results First Submitted : March 17, 2020
Results First Submitted that Met QC Criteria : August 13, 2020
Results First Posted : August 14, 2020

Last Update Submitted that Met QC Criteria : August 24, 2020
Last Update Posted : August 25, 2020